Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No studies are availabe for 3-methoxyestra-2,5(10)-dien-17-one (CAS number17976-32-8). Results 'read across' from studies with 3-methoxyestra-2,5(10)-dien-17ß-ol (CAS number1091-93-6) based on structural similarities as justified in the internal communication by R. Länge to J. Polomski (June 9, 2000).

The acute oral toxicity of the analogue was low with a LD50 value exceeding 2000 mg/kg bw in rats according to OECD TG 423. At the limit-dose 2000 mg/kg no animal died and no clinical signs, effects on body weight gain or gross pathological findings were observed during the 14-day post observation period.

The acute dermal toxicity of analogue was low with a LD50 value exceeding 2000 mg/kg bw in rats according to OECD TG 402. At the limit-dose 2000 mg/kg no animal died and no clinical signs, effects on body weight gain or gross pathological findings were observed during the 14-day post observation period.

Justification for classification or non-classification

Based on the study results of the analogue a classification according to Directive 67/548/EEC or Regulation (EC) No. 1272/2008 (CLP) is not warranted.